METHODS OF TREATMENT WITH MYOSIN MODULATOR
Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in clinical trials with mavacamten and with mavacamten and other myosin inhibitors in the pre-clinical setting, new insights into how myosin inhibitors can be used beneficially to impact the disease state of HCM and other diseases are provided herein..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 13. Dez. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
CARLSON TIMOTHY [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-12-13, Last update posted on www.tib.eu: 2023-12-26, Last updated: 2023-12-29 |
---|
Patentnummer: |
EP4054588 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA015355845 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA015355845 | ||
003 | DE-627 | ||
005 | 20231229105444.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230216s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA015355845 | ||
035 | |a (EPA)EP4054588 | ||
035 | |a (EPA)75849342 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a CARLSON TIMOTHY |e verfasserin |4 aut | |
245 | 1 | 0 | |a METHODS OF TREATMENT WITH MYOSIN MODULATOR |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-12-13, Last update posted on www.tib.eu: 2023-12-26, Last updated: 2023-12-29 | ||
520 | |a Disclosed herein are methods of treatment comprising administering a therapeutically effective amount of a myosin modulator or a pharmaceutically acceptable salt thereof to a subject in need thereof and diagnostic methods useful in connection with those treatments. Due to observations unfolding in clinical trials with mavacamten and with mavacamten and other myosin inhibitors in the pre-clinical setting, new insights into how myosin inhibitors can be used beneficially to impact the disease state of HCM and other diseases are provided herein. | ||
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a DEL RIO CARLOS L |4 aut | |
700 | 0 | |a EDELBERG JAY M |4 aut | |
700 | 0 | |a FERNANDES SARAH |4 aut | |
700 | 0 | |a HENZE MARCUS PATRICK |4 aut | |
700 | 0 | |a MA GRACE YANFEI |4 aut | |
700 | 0 | |a MCDOWELL ROBERT |4 aut | |
700 | 0 | |a MEALIFFE MATTHEW EDWARDS |4 aut | |
700 | 0 | |a SEHNERT AMY |4 aut | |
700 | 0 | |a SEMIGRAN MARC J |4 aut | |
700 | 0 | |a LAMPL KATHY L |4 aut | |
700 | 0 | |a ZHANG DAVID |4 aut | |
700 | 0 | |a DESAI MILIND Y |4 aut | |
700 | 0 | |a NISSEN STEVE |4 aut | |
700 | 0 | |a FANG LIANG |4 aut | |
700 | 0 | |a LAMBING JOSEPH |4 aut | |
700 | 0 | |a LI WANYING |4 aut | |
700 | 0 | |a AUBELE DANIELLE L |4 aut | |
700 | 0 | |a KANE BRIAN EDMUND |4 aut | |
700 | 0 | |a SEHL LOUIS CHARLES |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 13. Dez. |
773 | 1 | 8 | |g year:2023 |g day:13 |g month:12 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/75849342/publication/EP4054588A1?q=EP4054588 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 13 |c 12 |
951 | |a AR | ||
952 | |j 2023 |b 13 |c 12 |